COMMUNIQUÉS West-GlobeNewswire

Clairity Founder and CEO, Dr. Connie Lehman, Named to TIME’s 2026 TIME100 Health List
11/02/2026
A Global Leader in Breast Imaging and AI, Dr. Lehman is Advancing AI-Driven Risk Assessment to Identify Women at Elevated Risk Years Before Diagnosis TIME’s Annual List Recognizes 100 of the World’s Most Influential [...]
Dewpoint Therapeutics Selects First-in-Class MYC Condensate Modulator Development Candidate
11/02/2026
• First MYC condensate-modulating small molecule advanced to Development Candidate • Demonstrates potent, selective inhibition of MYC-driven transcription via condensate modulation • Preclinical data support potential [...]
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET
11/02/2026
REDWOOD CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced [...]
Wesley Pharmaceuticals Launches NAD+, Introducing a Signature Longevity and Skin Health Formulation to Its Product Lineup
11/02/2026
The premier 503B facility streamlines clinical access to its flagship NAD+ injection, offering an innovative wellness solution for Wesley’s nationwide client base ORLANDO, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Wesley [...]
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
11/02/2026
BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market [...]
Aveanna’s Heartways Program Receives CHAP Disease Program Certification
11/02/2026
ATLANTA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Community Health Accreditation Partner (CHAP), an independent, non-profit accrediting body for home and community-based healthcare, and Aveanna Healthcare (NASDAQ: AVAH), a [...]
Psyence BioMed Announces Settlement of Shareholder Litigation
11/02/2026
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (" Psyence BioMed " or the " Company ") today announced that it has entered into a settlement agreement to resolve a direct shareholder [...]
SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Shareholders
11/02/2026
NORTH PALM BEACH, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that it has redeemed 17,500 shares of its Series A Preferred Stock pursuant to [...]
Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma
11/02/2026
Prescription Drug User Fee Act (PDUFA) target action date set for September 28, 2026 If approved, Ameluz ® would be the first and only PDT photosensitizer indicated for the treatment of superficial Basal Cell Carcinoma [...]
Entera Bio Announces Open Market Purchases of Company Stock by Board Members
11/02/2026
TEL AVIV, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced that several members [...]
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
11/02/2026
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today [...]
Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026
11/02/2026
DUBLIN and BRIDGEWATER, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report fourth [...]
Denovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating Psychosis
11/02/2026
SAN DIEGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative drugs, today announced a partnership with Orygen to initiate a Phase 2 [...]
iMDx Announces $26.0 Million Registered Direct Offering
11/02/2026
NASHVILLE, Tenn., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (“iMDx” or the “Company”), today announced that it has entered into definitive agreements with certain [...]
Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women
11/02/2026
Pre-Fulfillment Prescribing Now Available in All 50 States, Supporting National Launch Developed and evaluated specifically for women, DARE to PLAY™ Sildenafil Cream is a first-of-its-kind female arousal cream, a non- [...]
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
11/02/2026
The Company is in Advanced Stage s of Commercial U.S. Partner ship Discussions for D-PLEX₁₀₀ Positive FDA Pre-NDA Feedback Supports Rolling NDA Review ; Submission Expected to Begin by the E nd of the First Quarter of [...]
HealthEdge® Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
11/02/2026
FRISCO, Texas and BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- HealthEdge ® , the technology and services company powering health plans’ most important value streams, today announced that it has achieved HITRUST r2 [...]
MBX Biosciences to Participate in Upcoming Investor Conferences
11/02/2026
CARMEL, Ind., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel precision peptide [...]
Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences
11/02/2026
LAGUNA HILLS, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Laseroptek America Corp. (“Laseroptek America” or “LOA”) today announced that it has filed counterclaims and third-party claims against Strata Skin Sciences, Inc [...]

Pages